Improving immunogenicity of influenza virus H7N9 recombinant hemagglutinin for vaccine development. 2019

Ting-Hui-Lin, and Min-Yuan Chia, and Chun-Yang Lin, and Yi-Qi Yeh, and U-Ser Jeng, and Wen-Guey Wu, and Min-Shi Lee
National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Zhunan, Miaoli County, Taiwan; College of Life Science, National Tsing-Hua University, Hsinchu, Taiwan.

Human infections of novel avian influenza A virus (H7N9) emerged in early 2013 and caused about 40% case-fatality through 2017. Therefore, development of influenza H7N9 vaccines is critical for pandemic preparedness. Currently, there are three means of production of commercial influenza vaccines: egg-based, mammalian cell-based, and insect cell-based platforms. The insect cell-based platform has the advantage of high speed in producing recombinant protein. In this study, we evaluate the stability and immunogenicity of two different influenza H7 HA expression constructs generated using the baculovirus system, including membrane-based full-length HA (mH7) and secreted ectodomain-based H7 (sH7). The mH7 construct could form an oligomer-rosette structure and had a high hemagglutinin (HA) titer 8192. In contrast to mH7, the sH7 construct could not form an oligomer-rosette structure and did not have HA titer before cross-linking with anti-His antibody. Thermal stability tests showed that the sH7 and mH7 constructs were unstable at 43 °C and 52 °C, respectively. In a mice immunization study, the mH7 construct but not the sH7 construct could induce robust HI and neutralizing antibody titers. In conclusion, further development of the mH7 vaccine candidate is desirable.

UI MeSH Term Description Entries
D007251 Influenza, Human An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia. Grippe,Human Flu,Human Influenza,Influenza in Humans,Influenza,Flu, Human,Human Influenzas,Influenza in Human,Influenzas,Influenzas, Human
D007252 Influenza Vaccines Vaccines used to prevent infection by viruses in the family ORTHOMYXOVIRIDAE. It includes both killed and attenuated vaccines. The composition of the vaccines is changed each year in response to antigenic shifts and changes in prevalence of influenza virus strains. The flu vaccines may be mono- or multi-valent, which contains one or more ALPHAINFLUENZAVIRUS and BETAINFLUENZAVIRUS strains. Flu Vaccine,Influenzavirus Vaccine,Monovalent Influenza Vaccine,Universal Flu Vaccine,Universal Influenza Vaccine,Flu Vaccines,High-Dose Trivalent Influenza Vaccine,Influenza Vaccine,Influenza Virus Vaccine,Influenza Virus Vaccines,Influenzavirus Vaccines,Intranasal Live-Attenuated Influenza Vaccine,LAIV Vaccine,Monovalent Influenza Vaccines,Quadrivalent Influenza Vaccine,Trivalent Influenza Vaccine,Trivalent Live Attenuated Influenza Vaccine,Universal Flu Vaccines,Universal Influenza Vaccines,Flu Vaccine, Universal,High Dose Trivalent Influenza Vaccine,Influenza Vaccine, Monovalent,Influenza Vaccine, Quadrivalent,Influenza Vaccine, Trivalent,Influenza Vaccine, Universal,Intranasal Live Attenuated Influenza Vaccine,Vaccine, Flu,Vaccine, Influenza,Vaccine, Influenza Virus,Vaccine, Influenzavirus,Vaccine, LAIV,Vaccine, Monovalent Influenza,Vaccine, Quadrivalent Influenza,Vaccine, Trivalent Influenza,Virus Vaccine, Influenza
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D005260 Female Females
D006385 Hemagglutination Inhibition Tests Serologic tests in which a known quantity of antigen is added to the serum prior to the addition of a red cell suspension. Reaction result is expressed as the smallest amount of antigen which causes complete inhibition of hemagglutination. Hemagglutination Inhibition Test,Inhibition Test, Hemagglutination,Inhibition Tests, Hemagglutination,Test, Hemagglutination Inhibition,Tests, Hemagglutination Inhibition
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000071497 Immunogenicity, Vaccine The capacity of VACCINES to stimulate the ADAPTIVE IMMUNE RESPONSE to produce antibodies and antigen-specific T-CELL responses. It is typically measured in vaccinated individuals in observational studies setting. Antigenicity, Vaccine,Vaccine Antigenicity,Vaccine Immunogenicity
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D015870 Gene Expression The phenotypic manifestation of a gene or genes by the processes of GENETIC TRANSCRIPTION and GENETIC TRANSLATION. Expression, Gene,Expressions, Gene,Gene Expressions

Related Publications

Ting-Hui-Lin, and Min-Yuan Chia, and Chun-Yang Lin, and Yi-Qi Yeh, and U-Ser Jeng, and Wen-Guey Wu, and Min-Shi Lee
June 2015, Journal of vaccines & vaccination,
Ting-Hui-Lin, and Min-Yuan Chia, and Chun-Yang Lin, and Yi-Qi Yeh, and U-Ser Jeng, and Wen-Guey Wu, and Min-Shi Lee
March 2019, Archives of virology,
Ting-Hui-Lin, and Min-Yuan Chia, and Chun-Yang Lin, and Yi-Qi Yeh, and U-Ser Jeng, and Wen-Guey Wu, and Min-Shi Lee
March 2015, Archives of virology,
Ting-Hui-Lin, and Min-Yuan Chia, and Chun-Yang Lin, and Yi-Qi Yeh, and U-Ser Jeng, and Wen-Guey Wu, and Min-Shi Lee
February 2001, Vaccine,
Ting-Hui-Lin, and Min-Yuan Chia, and Chun-Yang Lin, and Yi-Qi Yeh, and U-Ser Jeng, and Wen-Guey Wu, and Min-Shi Lee
May 2020, Viruses,
Ting-Hui-Lin, and Min-Yuan Chia, and Chun-Yang Lin, and Yi-Qi Yeh, and U-Ser Jeng, and Wen-Guey Wu, and Min-Shi Lee
January 2019, The Journal of infectious diseases,
Ting-Hui-Lin, and Min-Yuan Chia, and Chun-Yang Lin, and Yi-Qi Yeh, and U-Ser Jeng, and Wen-Guey Wu, and Min-Shi Lee
March 2018, Human vaccines & immunotherapeutics,
Ting-Hui-Lin, and Min-Yuan Chia, and Chun-Yang Lin, and Yi-Qi Yeh, and U-Ser Jeng, and Wen-Guey Wu, and Min-Shi Lee
October 2017, Antiviral research,
Ting-Hui-Lin, and Min-Yuan Chia, and Chun-Yang Lin, and Yi-Qi Yeh, and U-Ser Jeng, and Wen-Guey Wu, and Min-Shi Lee
November 2008, Influenza and other respiratory viruses,
Ting-Hui-Lin, and Min-Yuan Chia, and Chun-Yang Lin, and Yi-Qi Yeh, and U-Ser Jeng, and Wen-Guey Wu, and Min-Shi Lee
February 1976, Virology,
Copied contents to your clipboard!